Investor
The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share.
AI-powered value-based behavioral health company Ontrak and generative AI radiology workflow company Rad AI also garnered investments.
The behavioral health-focused company will use the Series A funds to accelerate product development and expand support for its customer base.
The company offers an at-home test where a breath sample is collected and analyzed by trained dogs and AI to detect early-stage cancer.
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
The company's filing comes two months after fellow digital musculoskeletal care company Hinge Health filed for IPO.
Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.
The funding comes on the heels of Carta Healthcare’s acquisition of Realyze Intelligence last year.
The announcement comes less than a year after Dexcom announced a strategic partnership and $75 million investment in the health-tracking ring maker.
It offers end-to-end, AI-driven digital ecosystem solutions for hospitals and insurers.